KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Biogen (BIIB) over the last 8 years, with Q4 2025 value amounting to $68.0 million.

  • Biogen's Depreciation and Depletion fell 659.34% to $68.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $272.8 million, marking a year-over-year decrease of 484.83%. This contributed to the annual value of $272.8 million for FY2025, which is 484.83% down from last year.
  • According to the latest figures from Q4 2025, Biogen's Depreciation and Depletion is $68.0 million, which was down 659.34% from $66.5 million recorded in Q3 2025.
  • Over the past 5 years, Biogen's Depreciation and Depletion peaked at $76.3 million during Q1 2022, and registered a low of $48.8 million during Q1 2021.
  • For the 5-year period, Biogen's Depreciation and Depletion averaged around $66.1 million, with its median value being $66.6 million (2021).
  • In the last 5 years, Biogen's Depreciation and Depletion skyrocketed by 5635.25% in 2022 and then tumbled by 1861.07% in 2023.
  • Quarter analysis of 5 years shows Biogen's Depreciation and Depletion stood at $66.6 million in 2021, then fell by 2.85% to $64.7 million in 2022, then fell by 1.85% to $63.5 million in 2023, then increased by 14.65% to $72.8 million in 2024, then fell by 6.59% to $68.0 million in 2025.
  • Its last three reported values are $68.0 million in Q4 2025, $66.5 million for Q3 2025, and $66.9 million during Q2 2025.